The purpose of this study is to determine whether or not the use of an equimolar mixture of oxygen and nitrous oxide during the physical therapy for patients suffering from frozen shoulder (adhesive shoulder capsulitis) results in a gain in shoulder amplitude (Constant Score) and less pain as compared to patients undergoing physical therapy without this treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
75
Kinesitherapy is performed with a mask by which patient inhales an equimolar oxygen-nitrous oxide mixture.
Kinesitherapy is performed with a mask by which patient inhales a placebo.
Unité Rééducation Réadaptation Locomotrice
Le Grau-du-Roi, Gard, France
Centre Hospitalier Universitaire de Nîmes
Nîmes, Gard, France
CHU de Clermont Ferrand
Clermont-Ferrand, France
CHU Lapeyronie
Montpellier, France
Change in the Constant Score using treatment as compared to without treatment.
The Constant score questionnaire consists of 11 questions that result in a final score ranging from 0 to 100. The higher the test result, the more normally the shoulder is functioning.
Time frame: fifteen days of physical therapy
Change in kinetics at final session since baseline of passive glenohumeral flexion of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of passive glenohumeral abduction of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of passive glenohumeral external rotation (ER1) of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of active global anterior flexion of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of active global lateral flexion of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of active global abduction of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Centre Hélio Marin
Vallauris, France
Change in kinetics at final session since baseline of active global external rotation (ER2) of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of active global internal rotation of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of passive global anterior flexion of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of passive global lateral flexion of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of passive global abduction of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Change in kinetics at final session since baseline of passive global external rotation (ER2) of the shoulder
Range of motion in degrees
Time frame: Final session on Day 15
Pain at visits
0-100 visual analogue scale (VAS)
Time frame: At each session: final session on Day 15
Pain induced during sessions
0-100 visual analogue scale (VAS)
Time frame: At each session: final session on Day 15
Functional improvement
Disabilities of the Arm Shoulder and Hand scale (DASH)
Time frame: Day 7
Functional improvement
Disabilities of the Arm Shoulder and Hand scale (DASH)
Time frame: Day 15
Functional improvement
Disabilities of the Arm Shoulder and Hand scale (DASH)
Time frame: Day 45
Functional improvement
Disabilities of the Arm Shoulder and Hand scale (DASH)
Time frame: Day 180
Limitations posed to the physiotherapist activity due to patient pain at each session
Likert six-point scale (none, to extremely high)
Time frame: At each session: final session on Day 15
patient satisfaction
0-10 VAS: 10=session interrupted due to pain; 0= session completed under perfect conditions
Time frame: At each session: final session on Day 15
Change in the Constant Score using treatment as compared to without treatment
Time frame: Day 7
Change in the Constant Score using treatment as compared to without treatment
Time frame: Day 45
Change in the Constant Score using treatment as compared to without treatment
Time frame: Day 180
Patient Quality of life
Medical Outcome Study Short Form-36 (MOS-SF36) score
Time frame: Day 1
Patient Quality of life
MOS-SF36 score
Time frame: Day 7
Patient Quality of life
MOS-SF36 score
Time frame: Day 15
Patient Quality of life
MOS-SF36 score
Time frame: Day 45
Patient Quality of life
MOS-SF36 score
Time frame: Day 180
Antalgic intake
Discriptively noted
Time frame: Until end of study (Day 180)